AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Plavas 75mg/75mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Aspirin (75mg) + Clopidogrel (75mg)

Overview Plavas 75mg/75mg Tablet

Combiflav 75mg/75mg tablets contain a dual antiplatelet formulation to inhibit clot formation within blood vessels. This medication prevents cardiovascular events like heart attacks and strokes in patients with pre-existing heart conditions, and also manages acute coronary syndrome (ACS). Consistent daily intake of Combiflav 75mg/75mg, alongside food, at regularly spaced intervals as directed by your physician, is crucial. Maintain a consistent dosing schedule to enhance adherence. Treatment length and dosage vary depending on the specific condition. Complete the prescribed course, regardless of symptom improvement. Lifestyle modifications—including a low-fat diet, regular exercise, and smoking cessation—can augment the medication's efficacy. Common adverse effects may include dyspepsia, easy bruising, and epistaxis. Increased bleeding risk necessitates caution with sharp objects. Alcohol consumption is generally discouraged during treatment. Prior to commencing treatment, disclose any hepatic or renal impairment, pregnancy, pregnancy intentions, or breastfeeding to your doctor. Inform your healthcare provider of all concurrent medications, as interactions are possible.

Uses of Plavas 75mg/75mg Tablet

Cardiovascular event prevention and acute coronary syndrome management

Major Benefits of Plavas 75mg/75mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Plavas 75mg/75mg Tablet should be administered with food.

Common Side effects of Plavas 75mg/75mg Tablet:

  • Bruise
  • Gastrointestinal bleeding
  • Increased bleeding tendency
  • Nosebleeds

How to use Plavas 75mg/75mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Plavas 75mg/75mg Tablet should be administered with a meal.

How Plavas 75mg/75mg Tablet works:

Each Plavas 75mg/75mg tablet combines aspirin and clopidogrel, two antiplatelet agents that help prevent heart attacks. This dual action inhibits platelet aggregation, thus reducing the risk of dangerous blood clots. The medication is also indicated for acute coronary syndrome management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption while taking Plavas 75mg/75mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Plavas 75mg/75mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Plavas 75mg/75mg tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Plavas 75mg/75mg tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Plavas 75mg/75mg tablets, as dose modification may be necessary. Consult a physician before use. Plavas 75mg/75mg tablets are contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Plavas 75mg/75mg Tablets cautiously, potentially requiring dose modification. Severe hepatic dysfunction contraindicates Plavas 75mg/75mg Tablet use; consult a physician for guidance.

What if you forget to take Plavas 75mg/75mg Tablet :

Should you forget a Plavas 75mg/75mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Plavas 75mg/75mg Tablet

LabelValue
Addictive None.
Medication Category HEMATOLOGICAL

FAQs on Plavas 75mg/75mg Tablet

Patients may receive Plavas 75mg/75mg Tablets following a heart attack, coronary artery stent placement, or coronary artery bypass grafting (CABG).
Plavas 75mg/75mg tablets function as an antiplatelet agent. By inhibiting platelet aggregation, these tablets help reduce the risk of blood clot formation. This mechanism contributes to the prevention of cardiovascular events such as stroke or heart attack in patients with pre-existing heart conditions, those recovering from a recent heart attack, or those experiencing unstable angina.
The prescribed length of Plavas 75mg/75mg Tablet treatment will be determined by your physician. This decision considers factors such as your diagnosis, the stent type, and any bleeding episodes during treatment. A typical minimum treatment course is one year. To maximize therapeutic effects, adhere strictly to your doctor's instructions regarding Plavas 75mg/75mg Tablet use. Never cease treatment independently; consult your doctor first. Abrupt cessation may increase the risk of stent thrombosis, heart attack, and even mortality.
Consuming alcohol alongside Plavas 75mg/75mg Tablet is discouraged due to an elevated risk of gastrointestinal hemorrhage. This can manifest as hematemesis (vomiting blood, potentially bright red or dark, coffee-ground-like) or melena (bloody or black, tarry stools). Consult your physician if you have any concerns.
Plavas 75mg/75mg Tablets can lead to severe, potentially fatal hemorrhaging. Increased bruising and prolonged bleeding from even minor wounds (e.g., shaving cuts) are also possible. Seek immediate medical care for excessive or persistent bleeding. Report dark, tarry stools or blood in the urine to your physician. Watch for stroke symptoms, including sudden numbness or weakness (unilateral or bilateral), gait difficulty, cognitive impairment, dysarthria, vertigo, and unexplained headaches. The occurrence of stroke, while infrequent, necessitates prompt medical intervention due to its life-threatening potential; contact your doctor immediately if these symptoms appear.
Preoperative or pre-treatment discontinuation of Plavas 75mg/75mg Tablet will be determined by your physician. Elective procedures may necessitate cessation of Plavas 75mg/75mg Tablet several days (typically seven) prior to the intervention to mitigate the heightened bleeding risk. Independent cessation of Plavas 75mg/75mg Tablet is inadvisable without prior consultation with your doctor.
Patients with a known allergy to Plavas 75mg/75mg Tablet or its components should not use this medication. The use of Plavas 75mg/75mg Tablet is contraindicated in individuals with a history of severe hepatic impairment, peptic ulcers, cerebral hemorrhage (including stroke or TIA), or hemophilia (a coagulation disorder). Furthermore, Plavas 75mg/75mg Tablet should be avoided by women who are pregnant, attempting conception, or lactating.
Should you miss a dose of Plavas 75mg/75mg Tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the forgotten dose and proceed with the next one as planned. Avoid doubling the dose to compensate for the missed dose, as this could heighten the risk of adverse reactions.
Minimize actions that could lead to bleeding. Exercise caution when shaving or brushing your teeth to avoid cuts. While painkillers should generally be avoided, if ibuprofen or a similar medication is necessary for pain relief (e.g., joint pain, headache, back pain), seek medical advice beforehand. Concurrent use of painkillers and Plavas 75mg/75mg Tablet may heighten the risk of stomach ulcers and bleeding. Similarly, excessive alcohol consumption with Plavas 75mg/75mg Tablet should be avoided due to the increased risk of stomach irritation and ulceration.
Plavas 75mg/75mg Tablet
24
MRP 29
16% off